Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,293 total articles
Porch Group, Inc. (NASDAQ: PRCH) reported that Chief Financial Officer Shawn Tabak executed a sale of 25,000 shares on July 2, 2026, generating $403,277 in proceeds. The transaction, facilitated by a Rule 10b5-1 trading plan established in November 2025, was designated to cover personal tax liabilities. This move occurs against a backdrop of mixed …
Nathan Kroeker, serving as both Chief Commercial Officer and Interim Chief Financial Officer at Eos Energy Enterprises, Inc. (NASDAQ:EOSE), executed a sale of company shares valued at $371,166, according to a recent SEC Form 4 filing. The transaction, which involved 79,309 shares sold at a weighted average price of $4.68, was facilitated through a …
Roku Media President Charles Collier sold approximately $2.9 million in Roku stock on July 6, 2026, while simultaneously exercising stock options to acquire an equal number of shares. The transactions, executed under a pre-arranged 10b5-1 plan, occur as Roku trades near its 52-week high and faces scrutiny from analysts following Fox Corporation's a…
TD SYNNEX CORP (NASDAQ: SNX) director Richard T. Hume has executed a sale of 5,000 common shares valued at $1,214,858. The transaction was facilitated through a Rule 10b5-1 trading plan established in early February 2026. This insider activity unfolds against a backdrop of robust corporate financial performance and optimistic analyst sentiment rega…
Xeris Biopharma Holdings Inc. (NASDAQ:XERS) Chief Financial Officer Steven Pieper completed the sale of 45,000 shares in early July 2026, realizing approximately $383,176 through a Rule 10b5-1 trading plan established in August 2025. The transaction coincides with a period of corporate restructuring, including leadership changes and patent developm…
Sunrun Inc. (NASDAQ: RUN) Chief Executive Officer Mary Powell executed a notable transaction involving the sale of 23,985 shares of the company's common stock on July 6, 2026. The transaction, valued at approximately $316,285, was necessitated by the requirement to cover tax obligations arising from the vesting of restricted stock units (RSUs). Thi…
Paul S. Dickson, President and Chief Revenue Officer at Sunrun Inc. (NASDAQ: RUN), executed a significant stock sale in early July, moving 15,613 shares for approximately $205,851. The transaction, filed with the SEC, was designated to cover tax liabilities from vested restricted stock units. This event occurs against a backdrop of strong Q1 2026 f…
Jeanna Steele, serving as the Chief Legal & People Officer for Sunrun Inc. (NASDAQ: RUN), executed a transaction involving the sale of 9,897 shares of the company's common stock on July 6, 2026. According to filings submitted to the Securities and Exchange Commission (SEC), the total value of these sales amounted to approximately $130,516. The tran…
Pelthos Therapeutics Inc. (PTHS) director Matthew Pauls completed a stock sale on July 2, 2026, disposing of 786 shares through a pre-arranged trading plan. The transaction, valued at $20,561, was structured to meet tax obligations arising from the vesting of restricted stock units. The sale occurred at prices ranging from $25.58 to $27.63, which c…
Sunrun Inc. (NASDAQ: RUN) Chief Financial Officer Danny Abajian executed a series of transactions on July 6, 2026, resulting in the disposal of company stock valued at $217,511. The sale was driven by tax obligations from vested restricted stock units. This activity occurs against a backdrop of Sunrun's strong first-quarter 2026 financial performan…
Pelthos Therapeutics Inc. director Ezra Friedberg executed a sale of 558 shares through a Rule 10b5-1 trading plan, citing tax obligations from restricted stock unit vesting as the primary driver. The transaction follows a period of significant price volatility and recent earnings misses, though the company has recently been added to several major …
Maria Barak, Sunrun's Chief Accounting Officer, executed a sale of 1,747 shares on July 6, 2026, totaling $23,013. The transaction, intended to cover tax obligations from vested restricted stock units, occurred as the stock trades at $12.20. Concurrently, the solar sector faces adjustments in deployment forecasts and potential import restrictions o…
Brian Grassadonia, who serves as the Ecosystem Lead at Block, Inc. (NYSE: SQ), executed a direct disposition of 43,348 shares of the company's Class A Common Stock on July 2, 2026. The transaction, valued at $3,467,840 based on a sale price of $80.00 per share, was facilitated under a Rule 10b5-1 trading plan established on June 2, 2025. Following …
Thomas P. Gallagher, Chairman and Chief Executive Officer of Miami International Holdings, Inc. (NASDAQ: MIAX), completed a series of stock transactions totaling approximately $2.95 million in early July 2026. The executive's activity involved both the sale of common stock and the exercise of nonqualified stock options, all conducted under a pre-ex…
Robinhood Markets, Inc. (NASDAQ:HOOD) Chief Brokerage Officer Steven M. Quirk executed a sale of company stock on July 2, 2026, moving $2.32 million worth of shares under a Rule 10b5-1 trading plan established in late 2025. The transaction occurs as the firm navigates a period of significant operational expansion, including new European product lin…
Pelthos Therapeutics Inc. (NASDAQ: PTHS) Director Peter Greenleaf executed a series of stock sales totaling $20,826 on July 2, 2026. The transactions, facilitated through a Rule 10b5-1 plan established in December 2025, were designated to cover tax liabilities associated with vesting restricted stock units. Following the divestment, Greenleaf retai…
Imunon Inc. (NASDAQ: IMNN) reported a recent equity transaction involving its General Counsel and Corporate Secretary, Susan Eylward. The filing details a sale of company stock shortly after an equity-based compensation grant, occurring against a backdrop of significant earnings misses and ongoing clinical trial financing. This activity highlights …
James R. Potts, Executive Vice President and General Counsel at Barrett Business Services Inc. (NASDAQ: BBSI), executed a series of stock sales totaling $332,021 in early July 2026. The transactions, conducted under a pre-arranged Rule 10b5-1 trading plan, reduce his direct holdings to 32,035 shares. The insider activity occurs as BBSI navigates a …
John J. Fitzgerald, a director at WidePoint Corp (NASDAQ:WYY), executed a significant divestment of company shares totaling $234,450 on July 6, 2026, according to a recent filing with the Securities and Exchange Commission. This transaction, involving the sale of 15,000 shares at a weighted average price of $15.63 per share, takes place against a b…
Robert Enslin, President and Chief Commercial Officer of Workday, Inc., executed two separate transactions on July 5, 2026, resulting in the sale of 11,008 shares of Class A Common Stock. The first sale, conducted under a Rule 10b5-1 trading plan, netted $724,971, while the second represented tax withholding on restricted stock unit vesting valued …
David A. Duffield, a prominent shareholder and founder of Workday, Inc. (NASDAQ:WDAY), executed a sale of Class A Common Stock valued at approximately $14.5 million on July 6, 2026. The transaction involved 107,500 shares sold at prices between $129.23 and $139.2999 per share. These sales were carried out under a Rule 10b5-1 trading plan, which fac…
Corebridge Financial CIO David Ditillo sold 4,250 shares on July 6, 2026, at $30.00 per share, totaling $127,500. The transaction was reported on July 7, 2026, via a Form 4 filing with the SEC. Post-transaction, Ditillo holds 128,153 shares, including 40,342 restricted stock units. Corebridge Financial's stock has risen to $30.60, reflecting a 7.6%…
Dolphin Entertainment, Inc. (NASDAQ:DLPN) Chief Executive Officer William O’Dowd IV recently executed a stock purchase totaling $4,983, acquiring 4,300 shares on July 6, 2026. This transaction occurs against a backdrop of a 26% year-to-date decline in the stock's price and recent financial reports showing revenue growth alongside persistent operati…
Martin C Bicknell, recognized as a ten percent owner of Palmer Square Capital BDC Inc., has executed a series of purchases totaling approximately $647,337 in the company's common stock. The transactions occurred on July 6 and July 7, 2026, and were facilitated indirectly through MCHC, LLC. This acquisition activity takes place against a backdrop of…
Kevin J. Knopp, President and CEO of 908 Devices Inc. (NASDAQ:MASS), executed a sale of company stock totaling $2,013 on July 2, 2026. The transaction involved 222 shares sold at prices between $9.062 and $9.07 per share under a Rule 10b5-1 trading plan adopted in May 2025. This sale occurs as the stock has experienced significant gains, trading ne…
